Drug transport mechanisms from Carbopol/Eudragit verapamil sustained-release tablets

Dissolution Technologies

Volumn 18, Issue 3, 2011, Pages 30-38

  Khamanga, Sandile M ^a   Walker, Roderick B ^a  

^a RHODES UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOMER; EUDRAGIT; MAGNESIUM STEARATE; VERAPAMIL;

ARTICLE; COMPARATIVE STUDY; DRUG RELEASE; DRUG SOLUBILITY; DRUG TRANSPORT; SUSTAINED RELEASE FORMULATION; TABLET FORMULATION; TABLET FRIABILITY;

EID: 80052749843     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/DT180311P30     Document Type: Article

References (35)

1. Polli, J. E.; Rekhi, G. S.; Shah, V. P. Methods to compare dissolution profiles. Drug Inf. J. 1996, 30, 1113-1120.
2. Siepmann, J.; Peppas, N. A. Mathematical modeling of controlled drug delivery. Adv. Drug Del. Rev. 2001, 48 (2-3), 137-138.
3. Huang, L. L.; Schwartz, J. B. Studies on drug release from a carbomer tablet matrix. Drug Dev. Ind. Pharm. 1995, 21 (13), 1487-1501.
4. Agarwal, V.; Mishra, B. Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine. Drug Dev. Ind. Pharm.1999, 25 (6), 701-709.
5. Khamanga, S. M.; Walker, R. B. Evaluation of rate of swelling and erosion of verapamil (VRP) sustained-release matrix tablets. Drug Dev. Ind. Pharm. 2006, 32 (10), 1139-1148.
6. Reis, M. A. A.; Sinisterra, R. D.; Belchior, J. C. An alternative approach based on artificial neural networks to study controlled drug release. J. Pharm. Sci. 2004, 93 (2), 418-430.
7. Peng, Y.; Geraldrajan, M.; Chen, Q.; Sun, Y.; Johnson, J. R.; Shukla, A. J. Prediction of dissolution profiles of acetaminophen beads using artificial neural networks. Pharm. Dev. Tech. 2006, 11 (3), 337-349.
8. Eisenberg, M. J.; Brox, A.; Bestawros, A. N. Calcium channel blockers: an update. Am. J. Med. 2004, 116 (1), 35-43.
9. Eudragit NE 30D data sheets. Evonik Industries, Evonik Röhm GmbH, Kirschenallee, Darmstadt, Germany.
10. Khamanga, S. M. M.; Walker, R. B. The Effects of Buffer Molarity, Agitation Rate, and Mesh Size on Verapamil Release from Modified-Release Mini-Tablets Using USP Apparatus 3. Dissolution Technol. 2007, 14 (2), 19-23.
11. Khamanga, S. M. M. Formulation and Assessment of Verapamil Sustained Release Tablets. M.Sc. Thesis, Rhodes University, Grahamstown, South Africa, 2005.
12. Moore, J. W.; Flanner, H. H. Mathematical comparison of curves with an emphasis on in vitro dissolution profiles. Pharm. Tech. 1996, 20 (6), 64-75.
13. Sathe, P. M.; Tsong, Y.; Shah, V. P. In-vitro dissolution profile comparison: Statistics and analysis, model dependent approach. Pharm. Res. 1996, 13 (12), 1799-1803.
14. Donbrow, M.; Samuelov, Y. Zero order drug delivery from double-layered porous films: release rate profiles from ethyl cellulose, hydroxypropyl cellulose and polyethylene glycol mixtures. J. Pharm. Pharmacol. 1980, 32 (7), 463-470.
15. Lapidus, H.; Lordi, N. G. Some factors affecting the release of a water-soluble drug from a compressed hydrophilic matrix. J. Pharm. Sci. 1966, 55 (8), 840-843.
16. Higuchi, T. Rate of release of medicaments from ointment bases containing drugs in suspension. J. Pharm. Sci. 1961, 50 (10), 874-875.
17. Higuchi, T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 1963, 52 (12), 1145-1149.
18. Costa, P.; Lobo, J. M. S. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001, 13 (2), 123-133.
19. Sood, A.; Panchagnula, R. Drug release evaluation of diltiazem CR preparations. Int. J. Pharm. 1998, 175 (1), 95-107.
20. Korsmeyer, R. W.; Gurny, R.; Doelker, E.; Buri, P.; Peppas, N. A. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983, 15 (1), 25-35.
21. Shan-Yang, L.; Hui-Ling, Y. Thermal stability of methacrylic acid copolymers of Eudragits L, S, and L30D and the acrylic acid polymer of carbopol. J. Polym. Sci., Part A: Polym. Chem. 1999, 37 (13), 2061-2067.
22. Carstensen, J. J.; Ping C. C. J. Flow rates and repose angles of wet-processed granulations. J. Pharm. Sci. 1977, 66 (9), 1235-1239.
23. Elkheshem, S.A. Interaction of verapamil hydrochloride with carbopol 934P and its effect on the release rate of the drug and the water uptake of the polymer matrix. Drug Dev. Ind. Pharm. 2001, 27 (9), 925-934.
24. Daly, P. B.; Davis, S. S.; Kennerly, J. W. The effect of anionic surfactants on the release of chlorpheniramine from a polymer matrix tablet. Int. J. Pharm. 1984, 18 (1-2), 201-205.
25. Sadeghi, F.; Ford, J. L.; Rajabi-Siahboomi, A. The influence of drug type on the release profiles from Sureleasecoated pellets. Int. J. Pharm. 2003, 254 (2), 123-135.
26. Neau, S. H.; Chow, M. Y.; Durrani, M. J. Fabrication and characterization of extruded and spheronized beads containing carbopol 974P, NF resin. Int. J. Pharm. 1996, 131 (1), 47-55.
27. Streubel, A.; Siepmann, J.; Dashevsky, A.; Bodmeier, R. pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets. J. Controlled Release 2000, 67 (1), 101-110.
28. Hasegawa, J.; Fujita, T.; Hayashi, Y.; Iwamoto, K.; Watanabe, J. pKa Determination of verapamil by liquid-liquid partition. J. Pharm. Sci. 2006, 73 (4), 442-445.
29. Jian-Hwa, G. Carbopol Polymers for Pharmaceutical Drug Delivery Applications (Excipient Update). Drug Dev. Deliv. [Online] 2003, 3 (6). http://www.drugdeliverytech.com/ME2/dirmod.asp?sid=4306B1E9C3CC4E07A4D64E23FBDB232C&nm=Back+Issues&type=Publishing&mod=Publications%3A%3AArticle&mid=8F3A7027421841978F18BE895F87F791&tier=4&id=C691909D749749438ABEF792F1A24A69 (accessed July 19, 2011).
30. Wells, M. L.; Parrott, E. L. Effect of surfactants on release of a highly water-soluble medicinal compound from an inert, heterogeneous matrix. J. Pharm. Sci. 1992, 81 (5), 453-457.
31. Yuasa, H.; Takahashi, H.; Ozeki, T.; Ueno, M. Application of the solid dispersion method to the controlled release of medicine. III: Control of the release of slightly water soluble medicine from solid dispersion granules. Chem. Pharm. Bull. 1993, 41 (2), 397-399.
32. Yuasa, H.; Takahashi, H.; Ozeki, T.; Kanaya, Y.; Ueno, M. Application of the solid dispersion method to the controlled release of medicine. VI: Release mechanism of a slightly water soluble medicine and interaction between flurbiprofen and hydroxypropyl cellulose in solid dispersion. Chem. Pharm. Bull. 1994, 42, 354-358.
33. Ozeki, H.; Yuasa, Kanaya Y. Application of the solid dispersion method to the controlled release of medicine. Difference in the release of flurbiprofen from solid dispersions with poly(ethylene oxide) and hydroxypropylcellulose and the interaction between medicine and polymers. Int. J. Pharm. 1997, 155 (2), 209-217.
34. Isoptin: verapamil hydrochloride. Royal Australian College of General Practitioners. Consumer Medicine Information. http://www.racgp.org.au/cmi/abcisopt.pdf (accessed July 23, 2011).
35. Dissolution Testing of Immediate Release Solid Oral Dosage Forms; Guidance for Industry; U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), U.S. Government Printing Office: Washington, DC, 1997.